G
Grand Pharmaceutical Group Limited
Hamilton
pharmaceutical technologynuclear medicine anti-tumor diagnosiscerebro-cardiovascular interventionbiotechnology
Grand Pharmaceutical Group Limited (stock code: 00512.HK) is a research-based international pharmaceutical enterprise specializing in pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, and biotechnology. The company operates multiple global R&D centers with over 770 R&D personnel and more than 147 projects in progress. It develops and commercializes innovative pharmaceutical products, including radiopharmaceuticals and interventional devices.
